Tech Company Financing Transactions

Emalex Biosciences Funding Round

Emalex Biosciences, based in Chicago, received $250 million in funding from Bain Capital Life Sciences, Fidelity Management & Research Company and Paragon Biosciences.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Mailing Address
330 N. Wabash 3500
Chicago, IL 60611
Email Address
Emalex is committed to addressing unmet medical needs by developing novel treatments for central nervous system movement disorders and fluency disorders. We partner with patient advocacy organizations to raise awareness of these disorders and support their education outreach and communication efforts.
Emalex Biosciences LinkedIn Company Profile
Social Media
Emalex Biosciences Company Twitter Account
Company News
Emalex Biosciences News
Emalex Biosciences on Facebook
Emalex Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Jeffrey Aronin
  Jeffrey Aronin LinkedIn Profile  Jeffrey Aronin Twitter Account  Jeffrey Aronin News  Jeffrey Aronin on Facebook
Vice President
Atul Mahableshwarkar
  Atul Mahableshwarkar LinkedIn Profile  Atul Mahableshwarkar Twitter Account  Atul Mahableshwarkar News  Atul Mahableshwarkar on Facebook
VP - Bus. Development
Eric Messner
  Eric Messner LinkedIn Profile  Eric Messner Twitter Account  Eric Messner News  Eric Messner on Facebook
VP - Manufacturing
Jay White
  Jay White LinkedIn Profile  Jay White Twitter Account  Jay White News  Jay White on Facebook
VP - Operations
David Kim
  David Kim LinkedIn Profile  David Kim Twitter Account  David Kim News  David Kim on Facebook
VP - R & D
Timothy Cunniff
  Timothy Cunniff LinkedIn Profile  Timothy Cunniff Twitter Account  Timothy Cunniff News  Timothy Cunniff on Facebook
VP - R & D
Stephen Wanaski
  Stephen Wanaski LinkedIn Profile  Stephen Wanaski Twitter Account  Stephen Wanaski News  Stephen Wanaski on Facebook
VP - Regulatory Affairs
Jenny Swalec
  Jenny Swalec LinkedIn Profile  Jenny Swalec Twitter Account  Jenny Swalec News  Jenny Swalec on Facebook



Browse more venture capital transactions:

Prev: 11/3/2022: Logiwa venture capital transaction
Next: 11/3/2022: Krepling venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary